|
US6331658B1
(en)
*
|
1993-04-20 |
2001-12-18 |
Integris Baptist Medical Center, Inc. |
Genetically engineered mammals for use as organ donors
|
|
US5849991A
(en)
*
|
1994-01-27 |
1998-12-15 |
Bresatch Limited |
Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
|
|
CA2196311A1
(en)
*
|
1994-08-19 |
1996-02-29 |
David H. Sachs |
Genetically engineered swine cells
|
|
US5865849A
(en)
*
|
1995-06-07 |
1999-02-02 |
Crosscart, Inc. |
Meniscal heterografts
|
|
US6046379A
(en)
*
|
1995-06-07 |
2000-04-04 |
Stone; Kevin R. |
Meniscal xenografts
|
|
US6231608B1
(en)
|
1995-06-07 |
2001-05-15 |
Crosscart, Inc. |
Aldehyde and glycosidase-treated soft and bone tissue xenografts
|
|
US5913900A
(en)
*
|
1995-06-07 |
1999-06-22 |
Corsscart, Inc. |
Substantially native meniscal cartilage heterografts
|
|
US5984858A
(en)
*
|
1995-06-07 |
1999-11-16 |
Crosscart, Inc. |
Meniscal xenografts
|
|
US6049025A
(en)
*
|
1995-09-15 |
2000-04-11 |
Stone; Kevin R. |
Articular cartilage xenografts
|
|
US5782915A
(en)
*
|
1995-09-15 |
1998-07-21 |
Stone; Kevin R. |
Articular cartilage heterografts
|
|
US5944755A
(en)
*
|
1995-09-15 |
1999-08-31 |
Crosscart, Inc. |
Articular cartilage xenografts
|
|
US6210440B1
(en)
|
1995-09-15 |
2001-04-03 |
Kevin R. Stone |
Anterior cruciate ligament xenografts
|
|
US5902338A
(en)
*
|
1995-09-15 |
1999-05-11 |
Crosscart, Inc. |
Anterior cruciate ligament heterograft
|
|
US6110206A
(en)
|
1995-09-15 |
2000-08-29 |
Crosscart, Inc. |
Anterior cruciate ligament xenografts
|
|
US6166288A
(en)
*
|
1995-09-27 |
2000-12-26 |
Nextran Inc. |
Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
|
|
WO1997016064A1
(en)
*
|
1995-11-03 |
1997-05-09 |
The Mount Sinai Medical Center |
Methods and compositions for the reduction of xenotransplantation rejection
|
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
|
WO1999044533A1
(en)
|
1998-03-06 |
1999-09-10 |
Crosscart, Inc. |
Soft tissue xenografts
|
|
US6383732B1
(en)
|
1999-02-11 |
2002-05-07 |
Crosscart, Inc. |
Method of preparing xenograft heart valves
|
|
US6972041B1
(en)
|
1998-03-16 |
2005-12-06 |
Crosscart, Inc. |
Bone xenografts
|
|
US6509187B2
(en)
*
|
1998-05-25 |
2003-01-21 |
Agrobiogen Gmbh |
Method and device for collection and preparation of tissue samples for molecular genetic diagnostics
|
|
JP2990268B1
(ja)
*
|
1998-08-31 |
1999-12-13 |
工業技術院長 |
機能性核酸転写用発現系
|
|
EP1115858B1
(de)
*
|
1998-09-25 |
2003-04-02 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Antisense-sequenzen für die hemmung der expression des adhäsionsmoleküls icam-1
|
|
WO2000022098A1
(en)
|
1998-10-12 |
2000-04-20 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
|
WO2000024912A1
(en)
*
|
1998-10-23 |
2000-05-04 |
The Children's Medical Center Corporation |
Use of a self-cleaving rna motif to modulate gene expression
|
|
US6700037B2
(en)
*
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
US6267786B1
(en)
|
1999-02-11 |
2001-07-31 |
Crosscart, Inc. |
Proteoglycan-reduced soft tissue xenografts
|
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
|
CA2385162A1
(en)
*
|
1999-09-30 |
2001-04-05 |
William L. Fodor |
Compositions and methods for altering gene expression
|
|
WO2001030992A2
(en)
*
|
1999-10-22 |
2001-05-03 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
α1-3 GALACTOSYLTRANSFERASE GENE AND PROMOTER
|
|
US7820878B2
(en)
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
|
US7074983B2
(en)
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
|
WO2001035735A1
(en)
*
|
1999-11-19 |
2001-05-25 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
|
DE60144248D1
(de)
|
2000-12-22 |
2011-04-28 |
Kyowa Hakko Kirin Co Ltd |
Verfahren zur klonierung von nichtmenschliche säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen
|
|
US20020142397A1
(en)
*
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
|
EP1373498A2
(en)
*
|
2001-03-21 |
2004-01-02 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
|
US7126039B2
(en)
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
|
US20030153044A1
(en)
*
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
|
US20030092174A1
(en)
*
|
2001-05-14 |
2003-05-15 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
|
US6702744B2
(en)
|
2001-06-20 |
2004-03-09 |
Advanced Cardiovascular Systems, Inc. |
Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
|
|
AU2002326353A1
(en)
*
|
2001-07-09 |
2003-01-29 |
Alexion Pharmaceuticals Inc. |
Cloned non-human mammals from contact inhibited donor cells
|
|
US8608661B1
(en)
|
2001-11-30 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Method for intravascular delivery of a treatment agent beyond a blood vessel wall
|
|
US7547816B2
(en)
|
2001-12-21 |
2009-06-16 |
The Curators Of The University Of Missouri |
α(1,3)-galactosyltransferase knockout swine, tissues and organs
|
|
JP2003225089A
(ja)
*
|
2002-02-04 |
2003-08-12 |
National Institute Of Agrobiological Sciences |
ブタｒａｇ−１遺伝子およびその利用
|
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
|
AU2003265415A1
(en)
*
|
2002-08-14 |
2004-03-03 |
Immerge Biotherapeutics, Inc. |
Alpha(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND Alpha(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM
|
|
DK1534819T3
(da)
|
2002-08-21 |
2010-04-19 |
Revivicor Inc |
Griselignende dyr, som mangler enhver ekspression af funktionel alfa-1,3-galactosyltransferase
|
|
WO2004044156A2
(en)
*
|
2002-11-08 |
2004-05-27 |
Hematech, Llc |
Transgenic ungulates having reduced prion protein activity and uses thereof
|
|
US8383158B2
(en)
*
|
2003-04-15 |
2013-02-26 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US8821473B2
(en)
|
2003-04-15 |
2014-09-02 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US8038991B1
(en)
|
2003-04-15 |
2011-10-18 |
Abbott Cardiovascular Systems Inc. |
High-viscosity hyaluronic acid compositions to treat myocardial conditions
|
|
WO2005009134A1
(en)
|
2003-07-21 |
2005-02-03 |
Lifecell Corporation |
ACELLULAR TISSUE MATRICES MADE FROM GALACTOSE α-1,3-GALACTOSE-DEFICIENT TISSUE
|
|
EP1685148A2
(en)
|
2003-11-05 |
2006-08-02 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
|
|
CN104721883A
(zh)
|
2004-03-17 |
2015-06-24 |
雷维维科公司 |
来源于缺乏任何功能性α1,3半乳糖基转移酶表达的动物的组织产品
|
|
NZ550106A
(en)
*
|
2004-04-22 |
2009-06-26 |
Kyowa Hakko Kirin Co Ltd |
Transgenic animals and uses thereof
|
|
WO2005117576A2
(en)
*
|
2004-05-28 |
2005-12-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Modification of sugar metabolic process in transgenic cells, tissues and animals
|
|
US20060148080A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Methods for supporting and producing human cells and tissues in non-human mammal hosts
|
|
US20060147429A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Facilitated cellular reconstitution of organs and tissues
|
|
US8303972B2
(en)
|
2005-04-19 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
|
US8187621B2
(en)
|
2005-04-19 |
2012-05-29 |
Advanced Cardiovascular Systems, Inc. |
Methods and compositions for treating post-myocardial infarction damage
|
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
|
US8828433B2
(en)
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US7732190B2
(en)
|
2006-07-31 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US9242005B1
(en)
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
|
US8741326B2
(en)
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US8192760B2
(en)
|
2006-12-04 |
2012-06-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating tissue using silk proteins
|
|
KR101149475B1
(ko)
|
2007-11-30 |
2012-05-25 |
한국생명공학연구원 |
이종 장기 이식용 미니 복제돼지 생산을 위한 유전자 조작된 세포주 및 그의 생산방법
|
|
KR101178946B1
(ko)
|
2008-02-01 |
2012-09-03 |
한국생명공학연구원 |
알파 1,3-갈락토실트랜스퍼라아제 유전자 타겟팅 벡터
|
|
KR101068479B1
(ko)
|
2008-07-30 |
2011-09-29 |
한국생명공학연구원 |
알파 1,3-갈락토실트랜스퍼라아제 유전자 타겟팅 벡터 및그의 용도
|
|
CA3104704A1
(en)
|
2009-08-14 |
2011-02-17 |
Revivicor, Inc. |
Multi-transgenic pigs for diabetes treatment
|
|
CN103492576A
(zh)
|
2011-02-14 |
2014-01-01 |
雷维维科公司 |
用于血管化异种移植物及其衍生物的异种移植的遗传修饰的猪
|
|
US9883939B2
(en)
|
2012-05-08 |
2018-02-06 |
The General Hospital Corporation |
Reducing immunogenicity of xenogeneic transplant tissues
|
|
US9980471B2
(en)
|
2012-06-12 |
2018-05-29 |
The General Hospital Corporation |
Miniature swine transgenic for one or more coagulation factors
|
|
EP3065790B1
(en)
|
2013-11-04 |
2020-10-28 |
LifeCell Corporation |
Methods of removing alpha-galactose
|
|
WO2018195402A1
(en)
|
2017-04-20 |
2018-10-25 |
Egenesis, Inc. |
Methods for generating genetically modified animals
|
|
US10883084B2
(en)
|
2018-10-05 |
2021-01-05 |
Xenotherapeutics, Inc. |
Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
|
|
KR20210089659A
(ko)
|
2018-10-05 |
2021-07-16 |
제노세라퓨틱스, 인코포레이티드 |
이종이식 생성물 및 방법
|
|
JP2023551404A
(ja)
|
2020-11-20 |
2023-12-08 |
レビビコア， インコーポレイテッド |
異種間移植のための成長ホルモン受容体ノックアウトを有する多重トランスジェニックブタ
|